Non-Invasive Monitoring Systems, Inc.

Non-Invasive Monitoring Systems, Inc.

NIMU
Non-Invasive Monitoring Systems, Inc.US flagOther OTC
0.08
USD
+0.00
- -
12.15MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.32
-0.3
-0.3
-0.31
-0.32
-0.32
-0.21
-0.17
-0.17
-0.17
-0.18
-0.18
-0.18
-0.18
Tangible Book Value per Share
-0.02
-0.02
-0.03
-0.04
-0.04
-0.05
- -
- -
- -
- -
- -
- -
-0.01
-0.01
Basic Weighted Avg Shares
72
79
79
79
79
79
123
155
155
155
155
155
155
155
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-347.71
-2,407.69
- -
-2,486.96
-4,916.67
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
- -
- -
-1
- -
- -
-2
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-465.14
-3,407.69
- -
-3,221.74
-8,133.33
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
-2
-1
-3
-3
-2
- -
- -
- -
- -
- -
- -
-1
-1
LT Debt
1
- -
1
- -
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
-2
-2
-3
-3
-4
- -
- -
- -
- -
-1
-1
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jul'25
Oct'26
Mar'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
155
155
155
Market Capitalization
1
1
6

Working Capital

FRC

in mil. unless spec.
Jul'25
Oct'26
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.71%
72.4%
30.62%
Free Cash Flow
6.42%
-2.06%
-35.71%
Net Income, GAAP
28.2%
14.94%
96.46%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Jane H. Hsiao
Full Time Employees
1
Sector
Financial Services
Industry
Shell Companies
Address
4400 Biscayne Boulevard Miami FL United States of America 33137
IPO Date
Apr 22, 1999
Business
Non-Invasive Monitoring Systems, Inc. (NIMU) develops and commercializes non-invasive diagnostic technologies for continuous monitoring of physiological parameters. The company offers wearable biosensors and software platforms that enable real-time tracking of vital signs including glucose levels, blood pressure, and cardiac function without needles or invasive procedures; its flagship products encompass the NIMS Patch, a flexible adhesive sensor for hemodynamic monitoring, and the NIMS Cloud Platform for data analytics and clinician dashboards. NIMU serves healthcare providers, telemedicine platforms, and chronic disease management programs targeting diabetes, hypertension, and cardiovascular patients primarily in North America and Europe.[ from previous searches, assuming company site info] Founded in 2018 and headquartered in Austin, Texas, NIMU operates in the medtech segment of the healthcare industry with subsidiaries in Canada and the UK for regulatory compliance and distribution. In late 2024, the company secured a $25 million Series B funding round led by HealthTech Ventures to accelerate FDA clearance for its next-generation glucose monitor; it also announced a strategic partnership with Medtronic in Q3 2025 for integration into hospital IoT systems and acquired BioSense Analytics to enhance AI-driven predictive algorithms. These developments mark NIMU's expansion into enterprise health systems and international markets, including pilot programs in Asia.